Passiflora edulis peel intake and ulcerative colitis: Approaches for prevention and treatment

Experimental Biology and Medicine

Volumn 239, Issue 5, 2014, Pages 542-551

  Cazarin, Cinthia B B ^a   da Silva, Juliana K ^a   Colomeu, Talita C ^a   Batista, Ângela G ^a   Vilella, Conceição A ^a   Ferreira, Anderson L ^a   Junior, Stanislau Bogusz ^a   Fukuda, Karina ^a   Augusto, Fabio ^a   de Meirelles, Luciana R ^a   Zollner, Ricardo de L ^a   Junior, Mário R Maróstica ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

antioxidant status; microbiota; Passiflora edulis peel; short chain fatty acids; ulcerative colitis

Indexed keywords

ALBUMIN; FLAVONOID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SHORT CHAIN FATTY ACID; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANTIOXIDANT ASSAY; ARTICLE; BACTERIAL LOAD; COLON FLORA; COLON MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; FOOD INTAKE; GAS CHROMATOGRAPHY; HISTOLOGY; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PASSION FRUIT; PH; RAT; ULCERATIVE COLITIS;

ANTIOXIDANT STATUS; MICROBIOTA; PASSIFLORA EDULIS PEEL; SHORT-CHAIN FATTY ACIDS; ULCERATIVE COLITIS;

ANIMALS; ANTIOXIDANTS; BACTERIA; BACTERIAL LOAD; CECUM; COLITIS, ULCERATIVE; DIET; DISEASE MODELS, ANIMAL; FATTY ACIDS, VOLATILE; HISTOCYTOCHEMISTRY; MALE; PASSIFLORA; POLYPHENOLS; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 84899675470     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214525306     Document Type: Article

References (66)

1. Baumgart DC,Sandborn WJ.Inflammatory bowel disease: clinical aspects and established and evolving therapies.Lancet. 2007;369:1641-57.
2. Rogler G,Andus T.Cytokines in inflammatory bowel disease.World J Surg. 1998;22:382-9.
3. Podolsky DK.Inflammatory bowel disease.N Engl J Med. 2002;347:417-29.
4. Galvez J,Rodriguez-Cabezas ME,Zarzuelo A.Effects of dietary fiber on inflammatory bowel disease.Mol Nutr Food Res. 2005;49:601-8.
5. Mylonaki M,Rayment NB,Rampton DS,Hudspith BN,Brostoff J.Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.Inflamm Bowel Dis. 2005;11:481-7.
6. Komiyama Y,Andoh A,Fujiwara D,Ohmae H,Araki Y,Fujiyama Y,Mitsuyama K,Kanauchi O.New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system.Scand J Gastroenterol. 2011;46:40-52.
7. Zhao HM,Huang XY,Zuo ZQ,Pan QH,Ao MY,Zhou F,Liu HN,Liu ZY,Liu DY.Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice.World J Gastroenterol. 2013;19:742-9.
8. Segain JP,Raingeard,de la,Bletiere D,Bourreille A,Leray V,Gervois N,Rosales C,Ferrier L,Bonnet C,Blottiere HM,Galmiche JP.Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.Gut. 2000;47:397-403.
9. Hu R,Ouyang Q,Wang H.Investigation of the effect of Na-butyrate on TNBS induced rat colitis.Sichuan Da Xue Xue Bao Yi Xue Ban. 2003;34:562-4.
10. Vieira EL,Leonel AJ,Sad AP,Beltrao NR,Costa TF,Ferreira TM,Gomes-Santos AC,Faria AM,Peluzio MC,Cara DC,Alvarez-Leite JI.Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis.J Nutr Biochem. 2012;23:430-6.
11. Roessner A,Kuester D,Malfertheiner P,Schneider-Stock R.Oxidative stress in ulcerative colitis-associated carcinogenesis.Pathol - Res Pract. 2008;204:511-24.
12. Roda G, Marocchi M, Sartini A, Roda E. Cytokine networks in ulcerative colitis. Ulcers 2011;2011: article ID 391787.
13. Strober W,Fuss IJ.Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases.Gastroenterology. 2011;140:1756-67.
14. Rodriguez-Peralvarez ML,Garcia-Sanchez V,Villar-Pastor CM,Gonzalez R,Iglesias-Flores E,Muntane J,Gomez-Camacho F.Role of serum cytokine profile in ulcerative colitis assessment.Inflamm Bowel Dis. 2012;18:1864-71.
15. Ruan EA,Rao S,Burdick JS,Stryker SJ,Telford GL,Otterson MF,Opara EC,Koch TR.Glutathione levels in chronic inflammatory disorders of the human colon.Nutr Res. 1997;17:463-73.
16. Nieto N,Torres MI,Fernandez MI,Giron MD,Rios A,Suarez MD,Gil A.Experimental ulcerative colitis impairs antioxidant defense system in rat intestine.Digest Dis Sci. 2000;45:1820-7.
17. de Faria FM, Luiz-Ferreira A, Socca EA, de Almeida AC, Dunder RJ, Manzo LP, da Silva MA, Vilegas W, Rozza AL, Pellizzon CH, Dos Santos LC, Souza Brito AR. Effects of Rhizophora mangle on experimental colitis induced by TNBS in rats. Evid Based Complement Alternat Med 2012;2012:753971.
18. Algieri F, Zorrilla P, Rodriguez-Nogales A, Garrido-Mesa N, Bañuelos Ó, González-Tejero MR, Casares-Porcel M, Molero-Mesa J, Zarzuelo A, Utrilla MP, Rodriguez-Cabezas ME, Galvez J. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis. J Ethnopharmacol 2013;146:750-9.
19. Camuesco D,Peran L,Comalada M,Nieto A,Di,Stasi LC,Rodriguez-Cabezas ME,Concha A,Zarzuelo A,Galvez J.Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.Inflamm Bowel Dis. 2005;11:265-71.
20. Hoentjen F,Welling GW,Harmsen HJ,Zhang X,Snart J,Tannock GW,Lien K,Churchill TA,Lupicki M,Dieleman LA.Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation.Inflamm Bowel Dis. 2005;11:977-85.
21. Lima de Albuquerque C,Comalada M,Camuesco D,Rodríguez-Cabezas ME,Luiz-Ferreira A,Nieto A,Monteiro de Souza Brito AR,Zarzuelo A,Gálvez J.Effect of kale and papaya supplementation in colitis induced by trinitrobenzenesulfonic acid in the rat.Eur e-J Clin Nutr Metabol. 2010;5:e111-6.
22. Scarminio V,Fruet AC,Witaicenis A,Rall VLM,Di Stasi LC.Dietary intervention with green dwarf banana flour (Musa sp AAA) prevents intestinal inflammation in a trinitrobenzenesulfonic acid model of rat colitis.Nutr Res. 2012;32:202-9.
23. Pinheiro EsR,Silva IMDA,Gonzaga LV,Amante ER,Teófilo RF,Ferreira MMC,Amboni RDMC.Optimization of extraction of high-ester pectin from passion fruit peel (Passiflora edulis flavicarpa) with citric acid by using response surface methodology.Bioresource Technol. 2008;99:5561-6.
24. Zeraik ML,Yariwake JH,Wauters J-N,Tits M,Angenot L.Analysis of passion fruit rinds (Passiflora edulis): isoorientin quantification by HPTLC and evaluation of antioxidant (radical scavenging) capacity.Química Nova. 2012;35:541-5.
25. Queiroz MSR, Janebro DI, Cunha MAL, Medeiros JS, Sabaa-Srur AUO, Diniz MFFM, Santos SC. Effect of the yellow passion fruit peel flour (Passiflora edulis f. flavicarpa deg.) in insulin sensitivity in type 2 diabetes mellitus patients. Nutr J 2012;11:89.
26. Lewis BJ, Herrlinger KA, Craig TA, Mehring-Franklin CE, Defreitas Z, Hinojosa-Laborde C. Antihypertensive effect of passion fruit peel extract and its major bioactive components following acute supplementation in spontaneously hypertensive rats. J Nutr Biochem 2013;24:1359-66.
27. Reeves PG,Nielsen FH,Fahey GC.Ain-93 purified diets for laboratory rodents - final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the Ain-76a Rodent Diet.J Nutr. 1993;123:1939-51.
28. Morris GP,Beck PL,Herridge MS,Depew WT,Szewczuk MR,Wallace JL.Hapten-induced model of chronic inflammation and ulceration in the rat colon.Gastroenterology. 1989;96:795-803.
29. Leite AV,Malta LG,Riccio MF,Eberlin MN,Pastore GM,Maróstica Júnior MR.Antioxidant potential of rat plasma by administration of freeze-dried jaboticaba peel (Myrciaria jaboticaba Vell Berg).J Agr Food Chem. 2011;59:2277-83.
30. Prior RL,Hoang H,Gu LW,Wu XL,Bacchiocca M,Howard L,Hampsch-Woodill M,Huang DJ,Ou BX,Jacob R.Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and food samples.J Agr Food Chem. 2003;51:3273-9.
31. Benzie IF,Strain JJ.Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration.Methods Enzymol. 1999;299:15-27.
32. Alam MN,Bristi NJ,Rafiquzzaman M.Review on in vivo and in vitro methods evaluation of antioxidant activity.Saudi Pharma J. 2013;21:143-52.
33. Bell CJ,Gall DG,Wallace JL.Disruption of colonic electrolyte transport in experimental colitis.Am J Physiol. 1995;268 (4 Pt 1): G622-30.
34. Ohkawa H,Ohishi N,Yagi K.Assay for lipid peroxides in animal-tissues by thiobarbituric acid reaction.Anal Biochem. 1979;95:351-8.
35. Favier AE, Cadet J, Kalyanaraman B, Fontecave M, Pierre JL. Analysis of free radicals in biological systems. Barsel, Boston, Berlim: Birkhauser Verlag; 1995.
36. Carlberg I,Mannervik B.Glutathione-reductase.Method Enzymol. 1985;113:484-90.
37. Yoshikawa T,Naito Y,Kishi A,Tomii T,Kaneko T,Iinuma S,Ichikawa H,Yasuda M,Takahashi S,Kondo M.Role of active oxygen, lipid-peroxidation, and antioxidants in the pathogenesis of gastric-mucosal injury-induced by indomethacin in rats.Gut. 1993;34:732-7.
38. Winterbourn CC,Hawkins RE,Brian M,Carrell RW.The estimation of red cell superoxide dismutase activity.J Lab Clin Med. 1975;85:337-41.
39. Krawisz JE,Sharon P,Stenson WF.Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.Gastroenterology. 1984;87:1344-50.
40. Chinen T, Komai K, Muto G, Morita R, Inoue N, Yoshida H, Sekiya T, Yoshida R, Nakamura K, Takayanagi R, Yoshimura A. Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance. Nat Commun 2011;2:190.
41. Asvarujanon P, Ishizuka S, Hara H. Promotive effects of non-digestible disaccharides on rat mineral absorption depend on the type of saccharide. Nutrition 2005;21:1025-35.
42. Zhao GH,Nyman M,Jonsson JA.Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography.Biomed Chromatogr. 2006;20:674-82.
43. Silva AFd,Schieferdecker MEM,Rocco CS,Amarante HMBdS.Food intake in patients with inflammatory bowel disease.ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2010;23:154-8.
44. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013; 145:970-7.
45. Liu S,Willett WC,Manson JE,Hu FB,Rosner B,Colditz G.Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women.Am J Clin Nutr. 2003;78:920-7.
46. Lattimer JM,Haub MD.Effects of dietary fiber and its components on metabolic health.Nutrients. 2010;2:1266-89.
47. Wanders AJ,van den,Borne JJGC,de,Graaf C,Hulshof T,Jonathan MC,Kristensen M,Mars M,Schols HA,Feskens EJM.Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials.Obes Rev. 2011;12:724-39.
48. Shamir R.Nutritional aspects in inflammatory bowel disease.J Pediatr Gastroenterol Nutr. 2009;48:S86-8.
49. Eiden KA.Nutritional considerations in inflammatory bowel disease.Pract Gastroenterol. 2003;XXVII:33-54.
50. Mijač DD,Janković GLJ,Jorga J,Krstić MN.Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment.Eur J Intern Med. 2010;21:315-9.
51. Celiński K,Dworzański T,Korolczuk A,Słomka M,Radej S,Piasecki R,Czechowska G.Comparison of main models of experimental colitis essential for studies on novel therapies of inflammatory bowel disease.Gastroenterol Polska. 2010;17:195-202.
52. Jones DP.Redefining oxidative stress.Antioxid Redox Signal. 2006;8:1865-79.
53. Dagli Ü,Balk M,Yücel D,Ülker A,Över H,Saydam G,Çahin B.The role of reactive oxygen metabolites in ulcerative colitis.Inflamm Bowel Dis. 1997;3:260-4.
54. Silva DC,Freitas AL,Pessoa CD,Paula RC,Mesquita JX,Leal LK,Brito GA,Goncalves DO,Viana GS.Pectin from Passiflora edulis shows anti-inflammatory action as well as hypoglycemic and hypotriglyceridemic properties in diabetic rats.J Med Food. 2011;14:1118-26.
55. Zeraik ML,Serteyn D,Deby-Dupont G,Wauters J-N,Tits M,Yariwake JH,Angenot L,Franck T.Evaluation of the antioxidant activity of passion fruit (Passiflora edulis and Passiflora alata) extracts on stimulated neutrophils and myeloperoxidase activity assays.Food Chem. 2011;128:259-65.
56. Kobayashi S,Murakami K,Sasaki S,Uenishi K,Yamasaki M,Hayabuchi H,Goda T,Oka J,Baba K,Ohki K,Watanabe R,Sugiyamama Y.Dietary total antioxidant capacity from different assays in relation to serum C-reactive protein among young Japanese women.Nutr J. 2012;11:91-91.
57. Cao G,Prior RL.Comparison of different analytical methods for assessing total antioxidant capacity of human serum.Clin Chem. 1998;44:1309-15.
58. Taverna M, Marie AL, Mira JP, Guidet B. Specific antioxidant properties of human serum albumin. Ann Intensive Care 2013;3:4.
59. Souza MSS, Barbalho SM, Damasceno DC, Rudge MV, de Campos KE, Madi AC, Coelho BR, Oliveira RC, de Melo RC, Donda VC. Effects of Passiflora edulis (yellow passion) on serum lipids and oxidative stress status of Wistar rats. J Med Food 2012;15:78-82.
60. Rudnicki M,de Oliveira MR,Veiga Pereira Td,Reginatto FH,Dal-Pizzol F,Fonseca Moreira JC.Antioxidant and antiglycation properties of Passiflora alata and Passiflora edulis extracts.Food Chem. 2007;100:719-24.
61. Abdalla EK,Caty MG,Guice KS,Hinshaw DB,Oldham KT.Arterial levels of oxidized glutathione (GSSG) reflect oxidant stress in vivo.J Surg Res. 1990;48:291-6.
62. Weber TE,Trabue SL,Ziemer CJ,Kerr BJ.Evaluation of elevated dietary corn fiber from corn germ meal in growing female pigs.J Anim Sci. 2010;88:192-201.
63. Teng Z,Qian L,Zhou Y.Hypolipidemic activity of the polysaccharides from Enteromorpha prolifera.Int J Biol Macromol. 2013;62:254-6.
64. Topping DL,Clifton PM.Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides.Physiol Rev. 2001;81:1031-64.
65. Hamer HM,Jonkers DM,Bast A,Vanhoutvin SA,Fischer MA,Kodde A,Troost FJ,Venema K,Brummer RJ.Butyrate modulates oxidative stress in the colonic mucosa of healthy humans.Clin Nutr. 2009;28:88-93.
66. Hamer HM,Jonkers DMAE,Vanhoutvin SALW,Troost FJ,Rijkers G,de,Bruine A,Bast A,Venema K,Brummer RJM.Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission.Clin Nutr. 2010;29:738-44.